Medication info
Sadipin 10/160 mg Tablet

Sadipin 10/160 mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›13.87mg / 1 tabletValsartan›160mg / 1 tablet
Manufacturer / importer
Unimed Pharmaceutical Co., Ltd.
Appearance
Bright yellow oval film-coated tablet
Packaging
30 tablets (10 tablets/PTP × 3)
Approval status
Active

MFDS item code 201500169 · Approved 2015.01.13 · Insurance code 649506330

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or those on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.
Child dose
Pediatric patients under 18 years of age: Administration of this drug is not recommended because its safety and efficacy have not been established.

Ingredients

Manufacturer
Unimed Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or valsartan.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or those on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.

Child dose

Pediatric patients under 18 years of age: Administration of this drug is not recommended because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm or death to the fetus if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Individuals allergic to the active ingredient or similar medications, pregnant or potentially pregnant women, breastfeeding women, and those with severe kidney or liver disease should not take this medication. Patients with sodium or fluid depletion, hyperkalemia, renal artery stenosis, recent kidney transplant, or a history of angioedema should use this medication very cautiously under strict medical supervision. Patients with heart failure or those who have had a myocardial infarction, aortic stenosis, or obstructive hypertrophic cardiomyopathy should also exercise caution when taking this medication. This medication may cause various side effects such as hypotension, dizziness, headache, edema, rash, and gastrointestinal disturbances; any unusual symptoms should be discussed with healthcare professionals immediately. Caution is advised when operating vehicles or machinery as dizziness or fatigue may occur. This medication may interact with other antihypertensive drugs, potassium supplements, diuretics, certain anti-inflammatories, and lithium preparations; it's essential to inform healthcare providers about any other medications being taken. Pregnant or breastfeeding women are advised not to take this medication, and it should also be avoided if pregnancy is planned. Use is not recommended for children under 18 years old, as safety and efficacy have not been established. In case of overdose, severe hypotension or heart-related issues may occur; thus, the prescribed dosage must be strictly followed, and immediate medical attention should be sought in case of overdose. Dose adjustments may be necessary for patients with liver and kidney function impairment, and regular blood tests and monitoring of physical condition are required.

Side effects

  • nasopharyngitis
  • influenza
  • hypersensitivity
  • visual impairment
  • anxiety
  • headache
  • dizziness
  • drowsiness
  • positional vertigo
  • sensory abnormality
Show 117 more
  • lightheadedness
  • tinnitus
  • tachycardia
  • palpitations
  • syncope
  • orthostatic hypotension
  • hypotension
  • cough
  • pharyngeal and laryngeal pain
  • diarrhea
  • nausea
  • abdominal pain
  • constipation
  • dry mouth
  • rash
  • erythema
  • hyperhidrosis
  • itching
  • joint swelling
  • low back pain
  • arthritis
  • muscle spasms
  • weakness
  • polyuria
  • nocturia
  • erectile dysfunction
  • edema
  • localized edema
  • facial swelling
  • peripheral edema
  • fatigue
  • flushing
  • asthenia
  • facial flushing
  • decreased hemoglobin
  • decreased hematocrit
  • neutropenia
  • thrombocytopenia
  • serum sickness related hypersensitivity
  • increased serum potassium
  • vasculitis
  • elevated liver function tests
  • angioedema
  • vesicular dermatitis
  • myalgia
  • renal failure
  • kidney damage
  • elevated serum creatinine
  • insomnia
  • reduced libido
  • pharyngitis
  • rhinitis
  • sinusitis
  • upper respiratory infection
  • viral infection
  • intestinal vascular edema
  • diplopia
  • thrombocytopenia
  • leukopenia
  • allergic reaction
  • hyperglycemia
  • insomnia
  • mood changes
  • tremors
  • sensory decrease
  • taste disturbance
  • peripheral neuropathy
  • hypertonia
  • arrhythmia
  • bradycardia
  • atrial fibrillation
  • ventricular tachycardia
  • myocardial infarction
  • vasculitis
  • dyspnea
  • rhinitis
  • vomiting
  • dyspepsia
  • pancreatitis
  • gastritis
  • gingival hyperplasia
  • hepatitis
  • jaundice
  • alopecia
  • purpura
  • skin depigmentation
  • photosensitivity reaction
  • angioedema
  • urticaria
  • erythema multiforme
  • Stevens-Johnson syndrome
  • myalgia
  • urinary disturbances
  • nocturnal enuresis
  • gynecomastia
  • pain
  • malaise
  • chest pain
  • weight loss
  • weight gain
  • elevated liver enzymes
  • chest discomfort
  • abdominal discomfort
  • gastroesophageal reflux disease
  • neck pain
  • hypercholesterolemia
  • hypoglycemia
  • neuroexcitability
  • sensory decrease
  • Stevens-Johnson syndrome
  • chest pain
  • weight gain
  • arthralgia
  • skeletal pain
  • rhabdomyolysis
  • gingival hyperplasia
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect from air and moisture. It's important to maintain storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Bright yellow oval film-coated tablet

Package unit

30 tablets (10 tablets/PTP × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.